Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Change in Inventory (2018 - 2026)

Sunshine Biopharma filings provide 8 years of Change in Inventory readings, the most recent being -$772796.0 for Q4 2025.

  • On a quarterly basis, Change in Inventory fell 142.82% to -$772796.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.6 million, a 72.74% decrease, with the full-year FY2025 number at $1.6 million, down 72.74% from a year prior.
  • Change in Inventory hit -$772796.0 in Q4 2025 for Sunshine Biopharma, down from $1.3 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $2.1 million in Q1 2024 to a low of -$772796.0 in Q4 2025.
  • Median Change in Inventory over the past 5 years was $376593.5 (2023), compared with a mean of $502429.3.
  • The widest YoY moves for Change in Inventory: up 2456.77% in 2022, down 702.72% in 2022.
  • Sunshine Biopharma's Change in Inventory stood at $34340.0 in 2021, then tumbled by 702.72% to -$206974.0 in 2022, then soared by 652.94% to $1.1 million in 2023, then surged by 57.71% to $1.8 million in 2024, then plummeted by 142.82% to -$772796.0 in 2025.
  • The last three reported values for Change in Inventory were -$772796.0 (Q4 2025), $1.3 million (Q3 2025), and $555075.0 (Q2 2025) per Business Quant data.